FDA Inspection
Merz Pharma Gmbh & Co. KGaAMerz Pharma Gmbh & Co. KGaA – FDA Inspection, Nov 6, 2024
Record Details
This FDA Inspection record concerns Merz Pharma Gmbh & Co. KGaA, with an inspection on November 6, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
- Company
- Merz Pharma Gmbh & Co. KGaA
- Inspection Date
- November 6, 2024
- Product Type
- Human Drugs
View Company Profile
ID · 9127e41f-f526-4b69-ba53-de858ab55019
Inspection Facts
- Inspection number
- 1268809
- FDA center
- Human Drugs
Other FDA inspections of Merz Pharma Gmbh & Co. KGaA
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 23, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merz Pharma Gmbh & Co. KGaA
- FDA Inspection 1132028 - 2019-08-23
- FDA Inspection 970804 - 2016-04-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.